North America holds a notable share of the FAM20B Gene Market, supported by a strong biotechnology ecosystem, advanced genomic research infrastructure, and rising adoption of precision medicine initiatives. Growing collaborations between academic institutions, pharmaceutical companies, and research organizations, along with continuous investments in life sciences innovation, continue to drive...